Patents by Inventor Mina HASSAN-ZAHRAEE

Mina HASSAN-ZAHRAEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11884726
    Abstract: The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: January 30, 2024
    Assignee: Pfizer Inc.
    Inventors: Fabio Cataldi, Robert A. Clare, Gail M. Comer, Vivekananda Pradhan, Alaa Ahmad, Mina Hassan-Zahraee, Mera Krishnan Tilley, Weidong Zhang, Anindita Banerjee, Karen Michelle Page, Michael Steven Vincent, David J. Von Schack
  • Publication number: 20230235070
    Abstract: The present invention relates to a method for treating inflammatory bowel disease (IBD) in a patient, the method comprising administering to the patient an anti-TNF-like ligand 1A (TL1A) antibody in an induction dosing regimen sufficient to improve signs and symptoms of IBD by at least 12 weeks after the start of treatment with the anti-TL1A antibody, said induction dosing regimen comprising a plurality of individual induction doses, wherein the method further comprises administering to the patient a subsequent maintenance dosing regimen after completion of the induction dosing regimen, said maintenance dosing regimen comprising a plurality of individual maintenance doses separated from each other by at least 2 weeks.
    Type: Application
    Filed: June 23, 2021
    Publication date: July 27, 2023
    Inventors: Mary Lynn BANIECKI, Mina HASSAN-ZAHRAEE, Kenneth Eugene HUNG, Gang LI, Li XI, Zhan YE
  • Publication number: 20210324070
    Abstract: The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
    Type: Application
    Filed: November 30, 2020
    Publication date: October 21, 2021
    Inventors: Fabio CATALDI, Robert A. CLARE, Gail M. COMER, Vivekananda PRADHAN, Alaa AHMAD, Mina HASSAN-ZAHRAEE, Mera Krishnan TILLEY, Weidong ZHANG, Anindita BANERJEE, Karen Michelle PAGE, Michael Steven VINCENT, David J. VON SCHACK
  • Patent number: 10851163
    Abstract: The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: December 1, 2020
    Assignee: PFIZER INC.
    Inventors: Fabio Cataldi, Robert A. Clare, Gail M. Comer, Vivekananda Pradhan, Alaa Ahmad, Mina Hassan-Zahraee, Mera Krishnan Tilley, Weidong Zhang, Anindita Banerjee, Karen Michelle Page, Michael Steven Vincent, David J. Von Schack
  • Publication number: 20180273619
    Abstract: The present invention provides a method for the treatment of a patient comprising administering to the patient an initial dose of between about 1 mg and about 150 mg of a MAdCAM antagonist antibody. Biomarkers for assessing a patient's response to anti-MAdCAM treatment are also provided.
    Type: Application
    Filed: January 6, 2016
    Publication date: September 27, 2018
    Inventors: Fabio CATALDI, Robert A. CLARE, Gail M. COMER, Vivekananda PRADHAN, Alaa AHMAD, Mina HASSAN-ZAHRAEE, Mera Krishnan TILLEY, Weidong ZHANG, Anindita BANERJEE, Karen Michelle PAGE, Michael Steven VINCENT, David J. VON SCHACK